Review of Noninvasive Imaging for Hypertrophic Cardiac Syndromes and Restrictive Physiology

Heart Failure Clinics

Volumn 2, Issue 2, 2006, Pages 215-230

  Fowler, Steven J ^a   Narula, Jagat ^a   Gurudevan, Swaminatha V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

CARDIOMEGALY; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; ECHOCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33744722758     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2006.04.001     Document Type: Review

References (103)

1. Zipes D.P., Libby P., Bonow R.O., et al. Braunwald's heart disease: a textbook of cardiovascular medicine. 7th edition. 2005
2. Maron B. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
3. Artz G.W.J. Restrictive cardiomyopathy. Curr Treat Options Cardiovasc Med 2 (2000) 431
4. Kushwaha S.S., Fallon J.T., and Fuster V. Medical progress: restrictive cardiomyopathy. N Engl J Med 336 (1997) 267-276
5. Hancock E.W. Cardiomyopathy: differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis. Heart 86 (2001) 343-349
6. Kern M. Hemodynamic rounds: interpretation of cardiac pathophysiology from pressure waveform analysis. 2nd edition. Wiley-Liss; 1999
7. Vaitkus P.T., and Kussmaul W.G. Constrictive pericarditis versus restrictive cardiomyopathy: a reappraisal and update of diagnostic criteria. Am Heart J 122 (1991) 1431-1441
8. Sagristà-Sauleda J.A., Angel J., Sánchez A., et al. Effusive-constrictive pericarditis. N Engl J Med 350 (2004) 469-475
9. Eltzschig H.K. Effusive-constrictive pericarditis [correspondence]. N Engl J Med 350 (2004) 2310-2312
10. Chinnaiyan K.M., Leff C.B., and Marsalese D.L. Constrictive pericarditis versus restrictive cardiomyopathy: challenges in diagnosis and management. Cardiol Rev 12 (2004) 314-320
11. Asher C.R., and Klein A.L. Diastolic heart failure: restrictive cardiomyopathy, constrictive pericarditis, and cardiac tamponade: clinical and echocardiographic evaluation. Cardiol Rev 10 (2002) 218-229
12. Otto C.M. Textbook of clinical echocardiography. 2nd edition. 2000
13. Sakamoto T. Apical hypertrophic cardiomyopathy (apical hypertrophy): an overview. J Cardiol 37 (2001) 161-178
14. Bhandari A.K.N.N. Myocardial texture characterization by two-dimensional echocardiography. Am J Cardiol 51 (1983) 817-825
15. Henein M.Y.G.D. Suppression of left ventricular early diastolic filling by long axis asynchrony. Br Heart J 73 (1995) 151-157
16. Rakowski H., Appleton C.P., Chan K.L., et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 9 (1996) 736-760
17. Garcia M., Thomas J.D., and Klein A. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32 (1998) 865-875
18. Oh J., Appleton C.P., Hatle L., et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 10 (1997) 246-270
19. Giannuzzi P., Imparato A., Temporelli P.L., et al. Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol 23 (1994) 1630-1637
20. Appleton C.P., Hatle L.K., and Popp R.L. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 12 (1988) 426-440
21. Appleton C.P., Jensen J.L., Hatle L.K., et al. Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. J Am Soc Echocardiogr 10 (1997) 271-292
22. Zile M.R., and Brutsaert D. New concepts in diastolic dysfunction and diastolic heart failure. Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 (2002) 1387-1393
23. Tei C. New noninvasive index for combined systolic and diastolic ventricular function. J Cardiol 26 (1995) 135-136
24. Nageuh S.F., Backinski L.L., Meyer D., et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104 (2001) 128-130
25. Nunez J., Zamorano J.L., Perez de Isla L., et al. Differences in regional systolic and diastolic function by Doppler tissue imaging in patients with hypertrophic cardiomyopathy and hypertrophy caused by hypertension. J Am Soc Echocardiogr 17 (2004) 717-722
26. Cardim N., Oliveira A.G., Longo S., et al. Doppler tissue imaging: regional myocardial function in hypertrophic cardiomyopathy and in athlete's heart. J Am Soc Echocardiogr 16 (2003) 223-232
27. Nagueh S.F., McFalls J., Meyer D., et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 108 (2003) 395-398
28. Kato T.S., Noda A., Izawa H., et al. Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 42 (2003) 278-285
29. Oki T., Tanaka H., Yamada H., et al. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall. Am J Cardiol 93 (2004) 864-869
30. De Backer J., Matthys D., Gillebert T.C., et al. The use of tissue Doppler imaging for the assessment of changes in myocardial structure and function in inherited cardiomyopathies. Eur J Echocardiogr 6 (2005) 243-250
31. D'Andrea A., D'Andrea L., Caso P., et al. The usefulness of Doppler myocardial imaging in the study of the athlete's heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy. Echocardiography 23 (2006) 149-157
32. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA guidelines for the clinical application of echocardiography. Circulation 95 (1997) 1686-1744
33. Germain P., Roul G., Kastler B., et al. Inter-study variability in left ventricular mass measurement: comparison between M-mode echocardiography and MRI. Eur Heart J 13 (1992) 1011-1019
34. Otterstad J.E., Froeland G., St-John Sutton M., et al. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function [see comments]. Eur Heart J 18 (1997) 507-513
35. van Royen N., Jaffe C.C., Krumholz H., et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide imaging for measuring left ventricular ejection fraction. Am J Cardiol 77 (1996) 843-850
36. Izumi C., Iga K., Sekiguchi K., et al. Usefulness of the transgastric view by transesophageal echocardiography in evaluating thickened pericardium in patients with constrictive pericarditis. J Am Soc Echocardiogr 15 (2002) 1004-1008
37. Schiavone W.A., Calafiore P.A., and Salcedo E.E. Transesophageal Doppler echocardiographic demonstration of pulmonary venous flow velocity in restrictive cardiomyopathy and constrictive pericarditis. Am J Cardiol 63 (1989) 1286-1288
38. Abdalla I.A., Murray R.D., Lee J.C., et al. Does rapid volume loading during transesophageal echocardiography differentiate constrictive pericarditis from restrictive cardiomyopathy?. Echocardiography 19 (2002) 125-134
39. Sutherland G.R., DiSalvo G., Herbats L., et al. Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial function. Review. J Am Soc Echocardiogr 17 (2004) 788-802
40. Kato T.S., Noda A., Izawa H., et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 110 (2004) 3808-3814
41. Koyama J., Davidoff R., and Falk R.H. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107 (2003) 2446-2452
42. Villanueva F.S., Wagner W.R., Vannan M.A., et al. Targeted ultrasound imaging using microbubbles. Cardiol Clin 22 (2004) 283-298
43. Monakier D., Woo A., Vannan M.A., et al. Myocardial contrast echocardiography in chronic ischemic and nonischemic cardiomyopathies. Cardiol Clin 22 (2004) 269-282
44. Van Camp G., Ay T., Pasquet A., et al. Quantification of myocardial blood flow and assessment of its transmural distribution with real-time power modulation myocardial contrast echocardiography. J Am Soc Echocardiogr 16 (2003) 263-270
45. Faber L. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. J Am Soc Echocardiogr 13 (2000) 1074-1079
46. Faber L., Seggewiss H., and Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 98 (1998) 2415-2421
47. Monaghan M.J. Role of real time 3D echocardiography in evaluating the left ventricle. Heart 92 (2006) 131-136
48. Jenkins C., Bricknell K., Hanekom L., et al. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using realtime three-dimensional echocardiography. J Am Coll Cardiol 44 (2004) 878-886
49. Kapetanakis S., Kearney M.T., Siva A., et al. Real-time three-dimensional echocardiography. A novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation 112 (2005) 992-1000
50. Zhang X., Ramachandra I., Liu Z., et al. Noninvasive three-dimensional electrocardiographic imaging of ventricular activation sequence. Am J Physiol Heart Circ Physiol 298 (2005) 2724-2732
51. Qin J.X., Shiota T., Lever H.M., et al. Impact of left ventricular outflow tract area on systolic outflow velocity in hypertrophic cardiomyopathy: a real-time three-dimensional echocardiographic study. J Am Coll Cardiol 39 (2002) 308-314
52. Sitges M., Qin J.X., Lever H.M., et al. Evaluation of left ventricular outflow tract area after septal reduction in obstructive hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study. Am Heart J 150 (2005) 852-858
53. Streeter Jr. D.D., Patel D.P., Sponitz H.M., et al. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res 24 (1969) 339-347
54. Hansen D.E., Daughters II G.T., and Alderman E.L. Effect of volume loading, pressure loading, and inotropic stimulation on left ventricular torsion in humans. Circulation 83 (1991) 1315-1326
55. Yun K.L., Niczyporuk M.A., Daughters II G.T., et al. Alterations in left ventricular diastolic twist mechanics during acute human cardiac allograft rejection. Circulation 83 (1991) 962-973
56. Young A.A., Kramer C.M., Ferrari V.A., et al. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Circulation 90 (1994) 854-867
57. Bohs L.N., Geiman B.J., Anderson M.E., et al. Speckle tracking for multi-dimensional flow estimation. Ultrasonics 38 (2000) 369-375
58. Notomi Y., Lysyansky P., Setser R.M., et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol 45 (2005) 2034-2041
59. Helle-Valle T., Crosby J., Edvardsen T., et al. New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 112 (2005) 3149-3156
60. Vannan M.A., Pedrizzetti G., Li P., et al. Effect of cardiac resynchronization therapy on longitudinal and circumferential left ventricular mechanics by velocity vector imaging: description and initial clinical application of a novel method using high-frame rate B-mode echocardiographic images. Echocardiography 22 (2005) 826-830
61. Benjelloun H., Cranney G.B., Kirk K.A., et al. Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function. Am J Cardiol 67 (1991) 1413-1420
62. Rickers C., Wilke N.M., Jerosch-Herold M., et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112 (2005) 855-861
63. Suzuki J., Shimamoto R., Nishikawa J., et al. Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging. J Am Coll Cardiol 33 (1999) 146-151
64. Spirito P., Seidman C.E., McKenna W.J., et al. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785 [see comments]
65. Francone M., Dymarkowski S., Kalantzi M., et al. Real-time cine MRI of ventricular septal motion: a novel approach to assess ventricular coupling. J Magn Reson Imaging 21 (2005) 305-309
66. Petitjean C., Rougon N., Cluzel P., et al. Quantification of myocardial function using tagged MR and cine MR images. Int J Cardiovasc Imaging 20 (2004) 497-508
67. Notomi Y., Setser R.M., Shiota T., et al. Assessment of left ventricular torsional deformation by Doppler tissue imaging: validation study with tagged magnetic resonance imaging. Circulation 111 (2005) 1141-1147
68. Kim R.J., Choi K.M., Judd R.M., et al. Assessment of myocardial viability by contrast enhancement (2003), Lippincott Williams and Wilkins, Philadelphia
69. Bogaert J., Goldstein M., Tannouri F., et al. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. Am J Roentgenol 180 (2003) 981-985
70. Mahrholdt H., Wagner A., Judd R.M., et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26 (2005) 1461-1474
71. Shah D.J., Judd R.M., and Kim R.J. Technology insight: MRI of the myocardium. Nat Clin Pract Cardiovasc Med 2 (2005) 597-605
72. Schaefer S. Magnetic resonance spectroscopy in human cardiomyopathies. J Cardiovasc Magn Reson 2 (2000) 151-157
73. Nakae I., Mitsunami K., Matsuo S., et al. Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy. Circ J 69 (2005) 711-716
74. Neubauer S., Krahe T., Schindler R., et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86 (1992) 1810-1818
75. Neubauer S., Horn M., Pabst T., et al. Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease. Eur Heart J 16 (1995) 115-118
76. Nakae I., Mitsunami K., Omura T., et al. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 42 (2003) 1587-1593
77. Diamant M., Lamb H.J., Groeneveld Y., et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42 (2003) 328-335
78. Chida K., Otani H., Saito H., et al. Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients. Acta Radiol 46 (2005) 386-390
79. Kondo C., Mori S., Endo M., et al. Real-time volumetric imaging of human heart without electrocardiographic gating by 256-detector row computed tomography: initial experience. J Comput Assist Tomogr 29 (2005) 694-698
80. Udelson J.E., Bonow R.O., and Dilsizian V. The historical and conceptual evolution of radionuclide assessment of myocardial viability. J Nucl Cardiol 11 (2004) 318-334
81. Dilsizian V., Rocco T.P., Strauss H.W., et al. Technetium-99m isonitrile myocardial uptake at rest. I. Relation to severity of coronary artery stenosis. J Am Coll Cardiol 14 (1989) 1673-1677
82. Dilsizian V., Rocco T.P., Freedman N.M., et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 323 (1990) 141-146
83. Bonow R.O., and Dilsizian V. Thallium 201 for assessment of myocardial viability. Semin Nucl Med 21 (1991) 230-241
84. Perrone-Filardi P., Bacharach S.L., Dilsizian V., et al. Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy. Am J Cardiol 72 (1993) 199-204
85. Dilsizian V., Bonow R.O., Epstein S.E., et al. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22 (1993) 796-804
86. Cannon III R.O., Dilsizian V., O'Gara P.T., et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 83 (1991) 1660-1667
87. Lee K.H., Jang H.J., Lee S.C., et al. Myocardial thallium defects in apical hypertrophic cardiomyopathy are associated with a benign prognosis. Thallium defects in apical hypertrophy. Int J Cardiovasc Imaging 19 (2003) 381-388
88. Thompson D.S., Naqvi N., Juul S.M., et al. Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. Br Heart J 44 (1980) 488-498
89. Alvares R.F., Shaver J.A., Gamble W.H., et al. Isovolumic relaxation period in hypertrophic cardiomyopathy. J Am Coll Cardiol 3 (1984) 71-81
90. Bonow R.O., Dilsizian V., Rosing D.R., et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 72 (1985) 853-864
91. Bonow R.O., Rosing D.R., Bacharach S.L., et al. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 64 (1981) 787-796
92. Cannon III R.O., Rosing D.R., Maron B.J., et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 71 (1985) 234-243
93. Maron B.J., Wolfson J.K., Epstein S.E., et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8 (1986) 545-557
94. Udelson J.E., Bonow R.O., O'Gara P.T., et al. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 79 (1989) 1052-1060
95. Cannon III R.O., Dilsizian V., O'Gara P.T., et al. Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy. Circulation 85 (1992) 1039-1045
96. Shimizu M., Ino H., Okeie K., et al. Cardiac sympathetic activity in the asymmetrically hypertrophied septum in patients with hypertension or hypertrophic cardiomyopathy. Clin Cardiol 23 (2000) 365-370
97. Li S.T., Tack C.J., Fananapazir L., et al. Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 35 (2000) 1867-1873
98. Sipola P., Vanninen E., Aronen H.J., et al. Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy. J Nucl Med 44 (2003) 487-493
99. Schelbert H. Metabolic imaging to assess myocardial viability. J Nucl Med 35 (1994) 8S-14S
100. Marin-Neto J.A., Dilsizian V., Arrighi J.A., et al. Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction. Am J Cardiol 82 (1998) 1001-1007
101. Knaapen P., Boellaard R., Gotte M.J., et al. The perfusable tissue index: a marker of myocardial viability. J Nucl Cardiol 10 (2003) 684-691
102. Knaapen P., Boellaard R., Gotte M.J., et al. Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. J Nucl Med 45 (2004) 1299-1304
103. Knaapen P., van Dockum W.G., Bondarenko O., et al. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy. Comparison between cardiac MRI and PET. J Nucl Med 46 (2005) 923-929